Biosimilar Newsletter Archive

  1. 07.31.25 -- Navigating FDA Regulatory Changes 7/31/2025
    07/31/25 Biosimilar Development Newsletter
  2. 07.25.25 -- Tools For Smarter Antibody Discovery 7/25/2025

    07/25/25 Biosimilar Development Newsletter

  3. 07.17.25 -- Bracing For The Impact Of The Federal Workforce Reduction 7/17/2025
    07/17/25 Biosimilar Development Newsletter
  4. 07.16.25 -- Helpful Biosafety Testing Innovations For mAbs Development And Manufacturing 7/16/2025

    07/16/25 Biosimilar Development Newsletter

  5. 07.13.25 -- Transitioning From Research To Commercialization: A Roadmap 7/13/2025
    07/13/25
  6. 07.10.25 -- Take a look at our useful PUPSIT overview and implementation resources. 7/10/2025

    07/10/25 Biosimilar Development Newsletter

  7. 07.10.25 -- Transitioning From Research To Commercialization: A Roadmap 7/10/2025

    07/10/25 Biosimilar Development Newsletter

  8. 07.03.25 -- How APBio Builds Multispecific Analytical Target Profiles 7/3/2025
    07/03/25 Biosimilar Development Newsletter
  9. 06.26.25 -- Formulation Is Key For Y-mAbs' Self-Assembling Antibody 6/26/2025
    06/26/25 Biosimilar Development Newsletter
  10. 06.19.25 -- Your helping hand in filtration for high concentration drugs. 6/19/2025

    06/19/25 Biosimilar Development Newsletter